- Report
- February 2025
- 185 Pages
Global
From €4017EUR$4,500USD£3,515GBP
- Report
- October 2025
- 184 Pages
Global
From €3164EUR$3,545USD£2,769GBP
€3516EUR$3,939USD£3,077GBP
- Report
- November 2025
- 367 Pages
Global
From €5222EUR$5,850USD£4,569GBP
- Report
- September 2025
- 250 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- November 2025
- 300 Pages
Global
From €3566EUR$3,995USD£3,120GBP
- Report
- September 2025
- 142 Pages
Global
From €2275EUR$2,549USD£1,991GBP
€2677EUR$2,999USD£2,342GBP
- Report
- September 2025
- 200 Pages
Global
From €2669EUR$2,990USD£2,335GBP
- Report
- November 2025
- 181 Pages
Global
From €3164EUR$3,545USD£2,769GBP
€3516EUR$3,939USD£3,077GBP
- Report
- November 2025
- 349 Pages
Global
From €5222EUR$5,850USD£4,569GBP
- Report
- September 2025
- 250 Pages
Global
From €4008EUR$4,490USD£3,507GBP
- Report
- November 2024
- 171 Pages
Global
From €5311EUR$5,950USD£4,647GBP
- Report
- February 2024
- 117 Pages
Global
From €4240EUR$4,750USD£3,710GBP
- Report
- April 2023
- 115 Pages
Global
From €4240EUR$4,750USD£3,710GBP

The Diagnostic Antibodies market is a subset of the Diagnostics industry, which focuses on the development and production of antibodies used to detect and diagnose diseases. Diagnostic antibodies are used to detect the presence of a specific antigen in a sample, such as a blood or tissue sample. These antibodies are used to diagnose a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. Diagnostic antibodies are also used to monitor the progression of a disease or to measure the effectiveness of a treatment.
The Diagnostic Antibodies market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Abcam, Bio-Rad, Merck, Thermo Fisher Scientific, and Roche. Show Less Read more